DISCOVER: How to Potentially Multiply Your Returns by Upto 5x...
Here is the latest financial fact sheet of Divis Laboratories. For more details, see the Divis Laboratories quarterly results and Divis Laboratories share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | -1.6 |
No. of shares | m | 265.47 |
% ch week | % | 1.7 |
% ch 1-mth | % | -5.0 |
% ch 12-mth | % | 60.7 |
52 week H/L | Rs | 3,913.0/1,632.7 |
No. of Mths Year Ending |
12 Mar-15* |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
5-Yr Chart Click to enlarge
|
---|
DIVIS LABORATORIES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 1,881 | 2,484 | 1,222 | 1,142 | 1,639 | |
Low | Rs | 1,217 | 918 | 784 | 533 | 1,115 | |
Sales per share (Unadj.) | Rs | 234.7 | 142.3 | 153.1 | 146.6 | 186.3 | |
Earnings per share (Unadj.) | Rs | 64.2 | 42.4 | 39.9 | 33.0 | 51.0 | |
Diluted earnings per share | Rs | 32.1 | 42.4 | 39.9 | 33.0 | 51.0 | |
Cash flow per share (Unadj.) | Rs | 74.4 | 46.9 | 44.6 | 38.4 | 57.3 | |
Dividends per share (Unadj.) | Rs | 20.00 | 10.00 | 10.00 | 10.00 | 16.00 | |
Adj. dividends per share | Rs | 10.00 | 10.00 | 10.00 | 10.00 | 16.00 | |
Dividend yield (eoy) | % | 1.3 | 0.6 | 1.0 | 1.2 | 1.2 | |
Book value per share (Unadj.) | Rs | 288.0 | 161.7 | 201.8 | 222.8 | 261.8 | |
Adj. book value per share | Rs | 144.0 | 161.7 | 201.8 | 222.8 | 261.8 | |
Shares outstanding (eoy) | m | 132.73 | 265.47 | 265.47 | 265.47 | 265.47 | |
Bonus/Rights/Conversions | - | - | - | - | - | ||
Price / Sales ratio | x | 6.6 | 12.0 | 6.6 | 5.7 | 7.4 | |
Avg P/E ratio | x | 24.1 | 40.1 | 25.1 | 25.3 | 27.0 | |
P/CF ratio (eoy) | x | 20.8 | 36.3 | 22.5 | 21.8 | 24.0 | |
Price / Book Value ratio | x | 5.4 | 10.5 | 5.0 | 3.8 | 5.3 | |
Dividend payout | % | 31.2 | 23.6 | 25.0 | 30.3 | 31.4 | |
Avg Mkt Cap | Rs m | 205,599 | 451,525 | 266,266 | 222,318 | 365,592 | |
No. of employees | `000 | 8.7 | 9.5 | 9.7 | 10.8 | 11.8 | |
Total wages/salary | Rs m | 2,904 | 3,612 | 4,999 | 4,561 | 5,423 | |
Avg. sales/employee | Rs Th | 3,571.8 | 3,983.1 | 4,175.0 | 3,616.0 | 4,175.1 | |
Avg. wages/employee | Rs Th | 333.0 | 381.0 | 513.5 | 423.8 | 457.7 | |
Avg. net profit/employee | Rs Th | 976.4 | 1,187.4 | 1,089.3 | 814.9 | 1,141.8 |
DIVIS LABORATORIES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 31,149 | 37,764 | 40,643 | 38,915 | 49,463 | |
Other income | Rs m | 447 | 974 | 749 | 1,134 | 1,556 | |
Total revenues | Rs m | 31,596 | 38,738 | 41,392 | 40,049 | 51,019 | |
Gross profit | Rs m | 11,652 | 14,174 | 14,460 | 12,617 | 18,718 | |
Depreciation | Rs m | 1,360 | 1,182 | 1,233 | 1,425 | 1,689 | |
Interest | Rs m | 19 | 38 | 23 | 13 | 35 | |
Profit before tax | Rs m | 10,721 | 13,928 | 13,953 | 12,313 | 18,551 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 2,206 | 2,671 | 3,349 | 3,543 | 5,023 | |
Profit after tax | Rs m | 8,515 | 11,258 | 10,604 | 8,770 | 13,527 | |
Gross profit margin | % | 37.4 | 37.5 | 35.6 | 32.4 | 37.8 | |
Effective tax rate | % | 20.6 | 19.2 | 24.0 | 28.8 | 27.1 | |
Net profit margin | % | 27.3 | 29.8 | 26.1 | 22.5 | 27.3 |
DIVIS LABORATORIES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 27,724 | 30,270 | 40,105 | 45,351 | 46,501 | |
Current liabilities | Rs m | 4,560 | 5,195 | 6,595 | 6,534 | 8,468 | |
Net working cap to sales | % | 74.4 | 66.4 | 82.5 | 99.7 | 76.9 | |
Current ratio | x | 6.1 | 5.8 | 6.1 | 6.9 | 5.5 | |
Inventory Days | Days | 136 | 117 | 119 | 127 | 131 | |
Debtors Days | Days | 87 | 85 | 81 | 95 | 86 | |
Net fixed assets | Rs m | 15,231 | 16,998 | 19,995 | 21,160 | 25,797 | |
Share capital | Rs m | 266 | 531 | 531 | 531 | 531 | |
"Free" reserves | Rs m | 37,958 | 42,402 | 53,043 | 58,625 | 68,962 | |
Net worth | Rs m | 38,223 | 42,933 | 53,574 | 59,156 | 69,493 | |
Long term debt | Rs m | 11 | 5 | 0 | 0 | 0 | |
Total assets | Rs m | 43,829 | 49,021 | 61,585 | 67,859 | 80,383 | |
Interest coverage | x | 577.4 | 369.5 | 618.4 | 926.8 | 531.0 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.7 | 0.8 | 0.7 | 0.6 | 0.6 | |
Return on assets | % | 19.5 | 23.0 | 17.3 | 12.9 | 16.9 | |
Return on equity | % | 22.3 | 26.2 | 19.8 | 14.8 | 19.5 | |
Return on capital | % | 28.1 | 32.5 | 26.1 | 20.8 | 26.7 | |
Exports to sales | % | 84.3 | 85.3 | 0 | 0 | 0 | |
Imports to sales | % | 23.9 | 22.9 | 25.2 | 21.8 | 24.6 | |
Exports (fob) | Rs m | 26,244 | 32,198 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 7,442 | 8,654 | 10,260 | 8,485 | 12,187 | |
Fx inflow | Rs m | 26,317 | 32,270 | 35,384 | 32,359 | 41,238 | |
Fx outflow | Rs m | 7,588 | 8,775 | 10,399 | 9,042 | 12,405 | |
Net fx | Rs m | 18,729 | 23,496 | 24,985 | 23,317 | 28,833 |
DIVIS LABORATORIES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 8,263 | 10,379 | 11,504 | 7,759 | 9,543 | |
From Investments | Rs m | -5,208 | -4,064 | -11,396 | -4,783 | -6,854 | |
From Financial Activity | Rs m | -3,030 | -6,311 | 24 | -3,142 | -2,459 | |
Net Cashflow | Rs m | 25 | 3 | 132 | -166 | 230 |
Share Holding
|
Company Information
|
CHM: Murali K. Divi (MD) | COMP SEC: P. V. Lakshmi Rajani | YEAR OF INC: 1990 | BSE CODE: 532488 | FV (Rs): 2 | DIV YIELD (%): 0.5 |
Read: DIVIS LABORATORIES 2018-19 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: SANOFI INDIA ORCHID PHARMA INDOCO REMEDIES SUVEN LIFE SCIENCES NOVARTIS
Compare DIVIS LABORATORIES With: SANOFI INDIA ORCHID PHARMA INDOCO REMEDIES SUVEN LIFE SCIENCES NOVARTIS
Compare DIVIS LABORATORIES With: ACTAVIS (US) ADCOCK INGRAM (S. Africa) MYLAN (US) TEVA PHARMA (Israel)
Indian share markets witnessed huge selling during closing hours on Friday and ended lower.
For the quarter ended December 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 27.9% YoY). Sales on the other hand came in at Rs 17 bn (up 19.1% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.
For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.
Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll show you how to get started on the path to daily trading profits.
An Indian company founded three decades ago in a garage caught my attention...
In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.
More